Navigation Links
Michael S. Watson, Ph.D., receives Am College of Medical Genetics-ACMG Foundation Presidents' Award
Date:4/4/2011

The ACMG and ACMG Foundation Presidents' Award has been newly established to thank and honor the valuable contributions made by a member of the American College of Medical Genetics. In a surprise announcement, Michael S. Watson, PhD, FACMG was named the first recipient of this new honor during the Presidential Plenary session at the 2011 ACMG Clinical Genetics Meeting in Vancouver, British Columbia in March.

"Despite the surprise, I am honored to have been the first recipient of this award. As with any award, thanks have to go to those who have allowed success to be realized including the many Boards of Directors and Committees of ACMG with which I have worked, the marvelous staff of the ACMG and ACMGF and the members of ACMG who work daily to deliver genetic services to patients," said Dr. Watson.

Dr. Watson received his B.S from American University in Washington, D.C. and his M.S. in Medical Genetics and Ph.D. in Physiology and Biophysics from the University of Alabama at Birmingham. He completed his postdoctoral fellowship in the Medical Genetics Training Program at Yale University School of Medicine. He has been Executive Director of the American College of Medical Genetics for the past 10 years and is an Adjunct Professor of Pediatrics at Washington University in St. Louis where he was Director of Clinical and Molecular Cytogenetics from 1986 2000. He is certified by the American Board of Medical Genetics in Clinical Cytogenetics and PhD Medical Genetics.

Dr. Watson has a long-standing interest in the translation of genetic information into health care use. He was a founder of the American College of Medical Genetics for which he has served as Vice President for Laboratory Affairs and has chaired its Test and Technology Transfer Committee, Economics Committee, Laboratory Practices Committee and Intellectual Property Committee. He co-chaired the NIH-ELSI/HHS Task Force on Genetics Testing from 1995 1997. Most recently, he was the project director for a MCHB/HRSA funded project to bring uniformity to newborn screening in the United States. He is currently the Director of the Health Resources and Services Administration (HRSA) funded National Coordinating Center for Regional Genetics and Newborn Screening for the Collaboratives and the Eunice Kennedy Shriver National Institute of Child Health and Human Development's Newborn Screening Translational Research Network (NBSTRN) Coordinating Center.

Dr. Watson has been the author of more than 100 peer-reviewed publications and book chapters.

"Mike Watson has been, without question, the most powerful force behind the success of the American College in Medical Genetics in establishing itself as the "go-to" authority on integration of genetics into medical practice," said ACMG's immediate past-president Bruce R. Korf, MD, PhD, FACMG. "There is no one in our community more deserving of our gratitude and recognition."

Dr. R. Rodney Howell, FACMG, president of the ACMG Foundation added, "Mike, as the first Executive Director of the American College of Medical Genetics, has been responsible for the dramatic expansion of the ACMG staff and the remarkable involvement of the organization in so many areas of genetics in the practice of medicine. With his outstanding leadership during this expansion, ACMG in the past ten years has demonstrated its critical role in the translation of genetic discoveries into the practice of medical genetics."


'/>"/>

Contact: Kathy Beal, MBA
kbeal@acmg.net
301-238-4582
American College of Medical Genetics
Source:Eurekalert

Related biology news :

1. 2011 HFSP Nakasone Award for Michael Elowitz of Caltech
2. Michael Graetzel wins the Millennium Technology Prize
3. Adult Star Katie Michaels Attending NHL Game 7 Red Wings vs. Coyotes
4. Michael Betenbaugh wins 2010 Cell Culture Engineering award
5. American Society for Microbiology honors J. Michael Miller
6. Pacific Biometrics, Inc. Announces the Appointment of Michael Murphy, PhD as Chief Operating Officer
7. Annual Michael & Susan Dell lectureship in child health
8. Autism Speaks chief science officer Geraldine Dawson, Ph.D., named Rock Star of Science
9. Marwan Khaled Tayeh, Ph.D., is awarded the 2010 Richard King Trainee Award
10. AACR applauds nomination of Francis S. Collins, M.D., Ph.D., to be the new NIH director
11. Sihoun Hahn, M.D., Ph.D., FACMG is the 2009-2010 Luminex/ACMGF Award recipient
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 ... of Infosys (NYSE: INFY ), and Samsung SDS, ... partnership that will provide end customers with a more ... payment services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) ... financial services, but it also plays a fundamental part in ...
(Date:4/15/2016)... 2016  A new partnership announced today will ... decisions in a fraction of the time it ... high-value life insurance policies to consumers without requiring ... Force Diagnostics, rapid testing (A1C, Cotinine and HIV) ... pressure, weight, pulse, BMI, and activity data) available ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys ... founding CEO, Barrett Bready , M.D., who returned ... of the original technical leadership team, including Chief Technology ... of Product Development, Steve Nurnberg and Vice President of ... to the company. Dr. Bready served as ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) is ... treatments and faster cures for prostate cancer. Members of the Class of 2016 ... countries. Read More About the Class of 2016 PCF ... ... ...
(Date:6/23/2016)... ... June 23, 2016 , ... Supplyframe, ... of the Supplyframe Design Lab . Located in Pasadena, Calif., the Design ... of how hardware projects are designed, built and brought to market. , The ...
(Date:6/23/2016)... LOUISVILLE, Ky. , June 23, 2016 /PRNewswire/ ... from two Phase 1 clinical trials of its ... double-blind, placebo-controlled, single and multiple ascending dose studies ... and pharmacodynamics (PD) of subcutaneous injection in healthy ... APL-2 subcutaneously (SC) either as a single dose ...
(Date:6/23/2016)... On Wednesday, June 22, 2016, the NASDAQ Composite ... Jones Industrial Average edged 0.27% lower to finish at 17,780.83; ... has initiated coverage on the following equities: Infinity Pharmaceuticals Inc. ... NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ ), ... more about these stocks by accessing their free trade alerts ...
Breaking Biology Technology: